{"entity":{"type":"insider","cik":"0001297318","url":"/insider/0001297318","json_url":"/insider/0001297318.json","name":"Mattila Jyrki","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2008-05-09","last":"2019-05-24","span_basis":"filed_date"},"name_variants":[{"name":"Mattila Jyrki","source":"filing","n_filings":5,"first_seen":"2008-05-09","last_seen":"2019-05-24"}],"transactions":[{"id":8726440,"accession":"0001062993-19-002408","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-19-002408","line_url":"/filing/0001062993-19-002408#line-3","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001297318","owner_name":"Mattila Jyrki","owner_display_name":"Mattila Jyrki","owner_url":"/insider/0001297318","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18750.0,"shares_display":"18,750","price_per_share":62.06,"price_display":"62.06","price_state":"stated","total_value":1163625.0,"total_display":"1,163,625.00","total_whole":"1,163,625","shares_owned_after":376.0,"shares_owned_after_display":"376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-22","filed_date":"2019-05-24","scope":"insider"},{"id":3970399,"accession":"0001209191-08-047480","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-047480","line_url":"/filing/0001209191-08-047480#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001297318","owner_name":"Mattila Jyrki","owner_display_name":"Mattila Jyrki","owner_url":"/insider/0001297318","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":40.06,"price_display":"40.06","price_state":"stated","total_value":350525.0,"total_display":"350,525.00","total_whole":"350,525","shares_owned_after":12099.0,"shares_owned_after_display":"12,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-12","filed_date":"2008-08-14","scope":"insider"},{"id":3712622,"accession":"0001209191-08-042891","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-08-042891","line_url":"/filing/0001209191-08-042891#line-5","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001297318","owner_name":"Mattila Jyrki","owner_display_name":"Mattila Jyrki","owner_url":"/insider/0001297318","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":38.09,"price_display":"38.09","price_state":"stated","total_value":914160.0,"total_display":"914,160.00","total_whole":"914,160","shares_owned_after":12099.0,"shares_owned_after_display":"12,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-16","filed_date":"2008-07-17","scope":"insider"},{"id":3712620,"accession":"0001209191-08-042891","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-042891","line_url":"/filing/0001209191-08-042891#line-3","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001297318","owner_name":"Mattila Jyrki","owner_display_name":"Mattila Jyrki","owner_url":"/insider/0001297318","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74340.0,"shares_display":"74,340","price_per_share":35.42,"price_display":"35.42","price_state":"stated","total_value":2633122.8,"total_display":"2,633,122.80","total_whole":"2,633,123","shares_owned_after":36099.0,"shares_owned_after_display":"36,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-15","filed_date":"2008-07-17","scope":"insider"},{"id":9265633,"accession":"0001209191-08-042888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-042888","line_url":"/filing/0001209191-08-042888#line-1","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001297318","owner_name":"Mattila Jyrki","owner_display_name":"Mattila Jyrki","owner_url":"/insider/0001297318","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90750.0,"shares_display":"90,750","price_per_share":30.45,"price_display":"30.45","price_state":"stated","total_value":2763337.5,"total_display":"2,763,337.50","total_whole":"2,763,338","shares_owned_after":13285.0,"shares_owned_after_display":"13,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-07","filed_date":"2008-07-17","scope":"insider"},{"id":3939713,"accession":"0001209191-08-029011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-029011","line_url":"/filing/0001209191-08-029011#line-3","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001297318","owner_name":"Mattila Jyrki","owner_display_name":"Mattila Jyrki","owner_url":"/insider/0001297318","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90750.0,"shares_display":"90,750","price_per_share":30.45,"price_display":"30.45","price_state":"stated","total_value":2763337.5,"total_display":"2,763,337.50","total_whole":"2,763,338","shares_owned_after":14140.0,"shares_owned_after_display":"14,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-07","filed_date":"2008-05-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875622","name":"BIOSPECIFICS TECHNOLOGIES CORP","url":"/issuer/0000875622","role":"Director","n_filings":1,"first_seen":"2019-05-24","last_seen":"2019-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Officer (Executive Vice President)","n_filings":4,"first_seen":"2008-05-09","last_seen":"2008-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001297318","retrieved_at":"2026-08-25T10:44:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}